AU4499697A - Method for treating parasitic diseases with proteasome inhibitors - Google Patents
Method for treating parasitic diseases with proteasome inhibitorsInfo
- Publication number
- AU4499697A AU4499697A AU44996/97A AU4499697A AU4499697A AU 4499697 A AU4499697 A AU 4499697A AU 44996/97 A AU44996/97 A AU 44996/97A AU 4499697 A AU4499697 A AU 4499697A AU 4499697 A AU4499697 A AU 4499697A
- Authority
- AU
- Australia
- Prior art keywords
- proteasome inhibitors
- parasitic diseases
- treating parasitic
- treating
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2589496P | 1996-09-13 | 1996-09-13 | |
US60025894 | 1996-09-13 | ||
PCT/US1997/017136 WO1998010779A1 (en) | 1996-09-13 | 1997-09-12 | Method for treating parasitic diseases with proteasome inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4499697A true AU4499697A (en) | 1998-04-02 |
Family
ID=21828635
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU44996/97A Abandoned AU4499697A (en) | 1996-09-13 | 1997-09-12 | Method for treating parasitic diseases with proteasome inhibitors |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4499697A (en) |
WO (1) | WO1998010779A1 (en) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8198270B2 (en) | 2004-04-15 | 2012-06-12 | Onyx Therapeutics, Inc. | Compounds for proteasome enzyme inhibition |
PT1745064E (en) | 2004-04-15 | 2011-03-23 | Proteolix Inc | Compounds for proteasome enzyme inhibition |
US7232818B2 (en) | 2004-04-15 | 2007-06-19 | Proteolix, Inc. | Compounds for enzyme inhibition |
EP1758921A2 (en) | 2004-05-10 | 2007-03-07 | Proteolix, Inc. | Compounds for proteasome enzyme inhibition |
EP1805208A2 (en) | 2004-10-20 | 2007-07-11 | Proteolix, Inc. | Labeled compounds for proteasome inhibition |
PL2261236T3 (en) | 2004-12-07 | 2015-12-31 | Onyx Therapeutics Inc | Composition for proteasome inhibition |
DE602006017359D1 (en) | 2005-05-27 | 2010-11-18 | Proteolix Inc | SUBSTRATE FOR RPN-11 ENZYME ACTIVITY |
MY145757A (en) | 2005-11-09 | 2012-04-13 | Proteolix Inc | Compounds for enzyme inhibition |
SI2041158T1 (en) | 2006-06-19 | 2013-09-30 | Onyx Therapeutics, Inc. | Peptide epoxyketones for proteasome inhibition |
DK2207791T4 (en) | 2007-10-04 | 2019-10-07 | Onyx Therapeutics Inc | CRYSTALLINIC PEPTIDE POXYKETON PROTEASE INHIBITORS AND SYNTHESIS OF AMINO ACID EPOXIDES |
ES2617560T3 (en) | 2008-10-21 | 2017-06-19 | Onyx Therapeutics, Inc. | Combination of the carfilzomib peptide epoxy ketone proteasome inhibitor with melphalan for use in the treatment of multiple myeloma |
TWI504598B (en) | 2009-03-20 | 2015-10-21 | Onyx Therapeutics Inc | Crystalline tripeptide epoxy ketone protease inhibitors |
JP5919196B2 (en) | 2009-11-13 | 2016-05-18 | オニキス セラピューティクス, インク.Onyx Therapeutics, Inc. | Use of peptide epoxy ketones for metastasis inhibition |
WO2011109355A1 (en) | 2010-03-01 | 2011-09-09 | Onyx Therapeutics, Inc. | Compounds for immunoproteasome inhibition |
EP2662094B1 (en) | 2012-05-08 | 2024-04-17 | Onyx Therapeutics, Inc. | Cylodextrin Complexation Methods for Formulating Peptide Proteasome Inhibitors |
US9309283B2 (en) | 2012-07-09 | 2016-04-12 | Onyx Therapeutics, Inc. | Prodrugs of peptide epoxy ketone protease inhibitors |
MX363455B (en) | 2012-07-18 | 2019-03-25 | Onyx Therapeutics Inc | Liposomal compositions of epoxyketone-based proteasome inhibitors. |
ES2667726T3 (en) | 2012-07-20 | 2018-05-14 | Cleave Biosciences, Inc. | Condensed pyrimidines as inhibitors of the p97 complex |
WO2014066506A2 (en) | 2012-10-23 | 2014-05-01 | Cleave Biosciences, Inc. | Compositions and methods for jamm protein inhibition |
UY35091A (en) | 2012-10-24 | 2014-05-30 | Onyx Therapeutics Inc | MODIFIED RELEASE FORMULATIONS FOR OPROZOMIB |
AR095426A1 (en) | 2013-03-14 | 2015-10-14 | Onyx Therapeutics Inc | TRIPEPTIDE INHIBITORS OF PROTEASA EPOXYCETONE |
UY35455A (en) | 2013-03-14 | 2014-09-30 | Onyx Therapeutics Inc | TRIPEPTIDIC INHIBITORS OF PROTEASA EPOXYCETONE |
US9296754B2 (en) | 2013-03-15 | 2016-03-29 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
WO2014151729A1 (en) | 2013-03-15 | 2014-09-25 | Irm Llc | Compounds and compositions for the treatment of parasitic diseases |
WO2014151630A2 (en) | 2013-03-15 | 2014-09-25 | Irm Llc | Compounds and compositions for the treatment of parasitic diseases |
TW201605832A (en) | 2013-12-10 | 2016-02-16 | 克立弗生物科學公司 | Monocyclic pyrimidine/pyridine compounds as inhibitors of p97 complex |
WO2015095477A1 (en) * | 2013-12-19 | 2015-06-25 | Irm Llc | [1,2,4]triazolo[1,5-a]pyrimidine derivatives as protozoan proteasome inhibitors for the treatment of parasitic diseases such as leishmaniasis |
KR101922317B1 (en) | 2014-01-20 | 2018-11-26 | 클리브 바이오사이언스 인코포레이티드 (클리브) | FUSED PYRIMIDINES AS INHIBITORS OF p97 COMPLEX |
CA3029032A1 (en) | 2016-06-29 | 2018-01-04 | Henry Johnson | Crystalline salts of peptide epoxyketone immunoproteasome inhibitor |
EP4296257A3 (en) | 2016-06-29 | 2024-03-20 | Kezar Life Sciences | Process of preparing a peptide epoxyketone immunoproteasome inhibitor |
US20180078532A1 (en) | 2016-09-21 | 2018-03-22 | Amgen Inc. | Immediate release formulations for oprozomib |
JP2018123119A (en) | 2016-12-14 | 2018-08-09 | アムジエン・インコーポレーテツド | Gastro-retentive modified release dosage forms for oprozomib and process to make the same |
WO2021142360A1 (en) | 2020-01-10 | 2021-07-15 | Amgen Inc. | Stable cyclodextrin free carfilzomib formulation |
WO2021142359A1 (en) | 2020-01-10 | 2021-07-15 | Amgen Inc. | Stable cyclodextrin free carfilzomib formulation |
-
1997
- 1997-09-12 AU AU44996/97A patent/AU4499697A/en not_active Abandoned
- 1997-09-12 WO PCT/US1997/017136 patent/WO1998010779A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1998010779A1 (en) | 1998-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4499697A (en) | Method for treating parasitic diseases with proteasome inhibitors | |
AU2543097A (en) | Method for treating pain | |
AU2587297A (en) | Method for treating pain | |
AU9035498A (en) | Method for treating pain | |
AU5382099A (en) | Apparatus and methods for radiotherapy | |
AU5268696A (en) | Novel compounds and methods for therapy | |
AU3146495A (en) | Methods for stereotactic implantation | |
AU4678399A (en) | System and method for refining search queries | |
AU2091101A (en) | Method and system for database query | |
AU7568698A (en) | Method and apparatus for dermatology treatment | |
AU1527897A (en) | Method for treating the prostate | |
AU8903798A (en) | Method and apparatus for tissue remodeling | |
AU3556297A (en) | Database apparatus | |
AU7383398A (en) | Therapeutic glasses and method for using the same | |
AU7534100A (en) | Apparatus for and method of searching | |
AU3825097A (en) | Method for tightening skin | |
AU2808997A (en) | Method for treating inflammation | |
AU5965396A (en) | Method for rapid enzymatic alcohol removal | |
AU5362598A (en) | Method for improving wastewater treatment | |
AU6198299A (en) | Device and method for sterilising screwcaps | |
AU2340897A (en) | Method for treating pain | |
AU2931695A (en) | Method for forming soles and device therefor | |
AU5733099A (en) | Method for treating ocular neovascular diseases | |
AU1337099A (en) | Method for identifying micro-organisms | |
AU2584597A (en) | Method for treating migraine pain |